Efrat Muller

Efrat Muller

Auto-generated profile, based on publicly available information

Efrat Muller

Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
EMEfrat Muller
Efrat Muller
ISItamar Shiryan
Itamar Shiryan
EBElhanan Borenstein
Elhanan Borenstein
Multi-omic studies of the human gut microbiome are crucial for understanding its role in disease across multiple functional layers. Nevertheless, integrating and analyzing such complex datasets poses significant challenges. Most notably, current analysis methods often yield extensive lists of disease-associated features (e.g., species, pathways, or metabolites), without capturing the multi-layered structure of the data. Here, we address this challenge by introducing “MintTea”, an intermediate integration-based approach combining canonical correlation analysis extensions, consensus analysis, and an evaluation protocol. MintTea identifies “disease-associated multi-omic modules”, comprising features from multiple omics that shift in concord and that collectively associate with the disease. Applied to diverse cohorts, MintTea captures modules with high predictive power, significant cross-omic correlations, and alignment with known microbiome-disease associations. For example, analyzing samples from a metabolic syndrome study, MintTea identifies a module with serum glutamate- and TCA cycle-related metabolites, along with bacterial species linked to insulin resistance. In another dataset, MintTea identifies a module associated with late-stage colorectal cancer, including Peptostreptococcus and Gemella species and fecal amino acids, in line with these species’ metabolic activity and their coordinated gradual increase with cancer development. This work demonstrates the potential of advanced integration methods in generating systems-level, multifaceted hypotheses underlying microbiome-disease interactions.

15 October 2022 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
EMEfrat Muller
Efrat Muller
YAYadid M. Algavi
Yadid M. Algavi
EBElhanan Borenstein
Elhanan Borenstein
Integrative analysis of microbiome and metabolome data obtained from human fecal samples is a promising avenue for better understanding the interplay between bacteria and metabolites in the human gut, in both health and disease. However, acquiring, processing, and unifying such datasets from multiple sources is a daunting and challenging task. Here we present a publicly available, simple-to-use, curated dataset collection of paired fecal microbiome-metabolome data from multiple cohorts. This data resource allows researchers to easily obtain multiple fully processed and integrated microbiome-metabolome datasets, facilitating the discovery of universal microbe-metabolite links, benchmark various microbiome-metabolome integration tools, and compare newly identified microbe-metabolite findings to other published datasets.

29 June 2020 in Blood Advances
Verified
Journal Article
Closed access
RSRoni Shouval
Roni Shouval
AEAdi Eshel
Adi Eshel
BDBar Dubovski
Bar Dubovski
AKAmir A. Kuperman
Amir A. Kuperman
IDIvetta Danylesko
Ivetta Danylesko
OKOmry Koren
Omry Koren
Oral mucositis (OM) is a common debilitating dose-limiting toxicity of cancer treatment, including hematopoietic stem cell transplantation (HSCT). We hypothesized that the oral microbiome is disturbed during allogeneic HSCT, partially accounting for the variability in OM severity. Using 16S ribosomal RNA gene sequence analysis, metabolomic profiling, and computational methods, we characterized the behavior of the salivary microbiome and metabolome of 184 patients pre- and post-HSCT. Transplantation was associated with a decrease in oral α diversity in all patients. In contrast to the gut microbiome, an association with overall survival was not detected. Among 135 patients given methotrexate for graft-versus-host disease prophylaxis pre-HSCT, Kingella and Atopobium abundance correlated with future development of severe OM. Posttransplant, Methylobacterium species were significantly enriched in patients with severe OM. Moreover, the oral microbiome and metabolome of severe OM patients underwent distinct changes post-HSCT, compared with patients with no or mild OM. Changes in specific metabolites were well explained by microbial composition, and the common metabolic pathway was the polyamines pathway, which is essential for epithelial homeostasis. Together, our findings suggest that salivary microbial composition and metabolites are associated with the development of OM, offering new insights on pathophysiology and potential avenues of intervention.

22 October 2025 in Aging Cell
Verified
Journal Article
Open access
BHBenjamin Harrison
Benjamin Harrison
MPMaria Partida-Aguilar
Maria Partida-Aguilar
AMAbbey Marye
Abbey Marye
DDDanijel Djukovic
Danijel Djukovic
MKMandy Kauffman
Mandy Kauffman
DPDaniel E L Promislow
Daniel E L Promislow
Our understanding of aging has grown through the study of systems biology, including single‐cell analysis, proteomics and metabolomics. Studies in lab organisms in controlled environments, while powerful and complex, fall short of capturing the breadth of genetic and environmental variation in nature. Thus, there is now a major effort in geroscience to identify aging biomarkers that might be applied across the diversity of humans and other free‐living species. To meet this challenge, the Dog Aging Project (DAP) aims to identify cross‐sectional and longitudinal patterns of aging in complex systems, and how these are shaped by the diversity of genetic and environmental variation among companion dogs. Here we surveyed the plasma metabolome from the first year of sampling of the Precision Cohort of the DAP. By incorporating extensive metadata and whole genome sequencing, we overcome the limitations inherent in breed‐based estimates of genetic effects, and probe the physiological basis of the age‐related metabolome. We identified effects of age on approximately 36% of measured metabolites. We also discovered a novel biomarker of age in the post‐translationally modified amino acids (ptmAAs). The ptmAAs, which are generated by protein hydrolysis, covaried both with age and with other biomarkers of amino acid metabolism, and in a way that was robust to diet. Clinical measures of kidney function mediated about half of the age effect on ptmAA levels. This work identifies ptmAAs as robust indicators of age in dogs, and points to kidney function as a physiological mediator of age‐associated variation in the plasma metabolome.

6 November 2019
Verified
Dataset
Closed access
EBElhanan Borenstein
Elhanan Borenstein
EMEfrat Muller
Efrat Muller
Meta-analysis studies have been widely used in medical research, psychology, economics and other domains with the goal of synthesizing results of multiple studies tackling the same hypothesis. The field of high-throughput biology shortly followed, with, for example, GWAS meta-analysis studies {1}, gene expression microarray datasets {2}, and others. Only a few meta-analysis studies have been performed in the specific domain of human microbiome research to date. One of the most interesting among them is this paper, by Duvallet et al. In this meta-analysis, they obtained data from 30 studies spanning 13 diseases/conditions. The analysis they performed targeted questions such as "can we identify microbial biomarkers for certain conditions that are consistent across many patient cohorts?", "are different diseases characterized by distinct shifts in the gut microbiome?", and "are some bacteria part of a non-specific “diseased” microbiome and consistently associated with disease in general?". They find that different diseases demonstrate different dysbiosis patterns. Colorectal cancer (for example) is characterized by an elevation of disease-associated bacteria, while IBD is associated with depletion of health-associated bacteria. They also find that on average, over half of the disease-microbe associations found in a differential abundance analysis of a specific case-control study may actually be non-specific to that disease, and rather characterize many different diseases. This finding should serve as a cautionary note when interpreting results of differential abundance analysis of a specific case-control study.

2 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TBTal Bamberger
Tal Bamberger
EMEfrat Muller
Efrat Muller
YAYadid M. Algavi
Yadid M. Algavi
AGAshlee Greenier
Ashlee Greenier
CAChristine Adjangba
Christine Adjangba
EBElhanan Borenstein
Elhanan Borenstein
Companion dogs ( Canis lupus familiaris ) offer a unique model for studying the gut microbiome and its relation to aging due to their cohabitation with humans, sharing similar environments, diets, and healthcare practices. Here, we present the Dog Aging Project (DAP) Precision cohort, the largest population-wide study of the canine gut microbiome to date. This cohort encompasses over 900 dogs of diverse breeds, environments, and demographics living across the United States. Coupling fecal shotgun metagenomic sequencing with comprehensive phenotypic and environmental surveys and clinical lab tests, we explore the intricate relationships between microbiome composition, aging, and key factors such as diet, health, and living conditions. Our analyses identify various factors associated with microbiome composition. In addition, we find a gradual shift in microbiome composition with age, which allows us to develop a novel metagenomics-based “clock” to predict biological aging based on microbial signatures. Overall, these findings provide an unprecedented and detailed understanding of the role the gut microbiome plays in our four-legged companions, offering both potential applications in veterinary medicine and an exciting model for aging research.